Summary
54 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- Out of every 100 EUR of revenue, 11 EUR is left as free cash.
What to watch
- Revenue grew by only 0.0% a year over the last 3 years.
- It earns only 6.3 EUR a year on every 100 EUR of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 19.9 EUR for 1 EUR of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (EUR)
Diluted EPS (EUR)
- Analyst estimate
Revenue grew by 0.6% a year over 5 years. Over the last 3 years it grew by 0.0% a year. For the next fiscal year analysts expect revenue to grow by 2.3%.
Growth in detailDoes it make money?
ReasonablyWhere 100 EUR of revenue goes
- Cost of sales 54 EUR
- Research and development 9.7 EUR
- Sales and administration 26 EUR
- Taxes and other 3.4 EUR
- Net profit 6.3 EUR
Net profit, industry median (Medical - Devices) 6.9 EUR
Out of every 100 EUR of revenue, 6.3 EUR is left as net profit.
Profitability in detailIs it financially healthy?
MostlyRepaying all its debt would take 3.9 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Moderate, stretched- Yield
- 3.97%
- Paid out of profit
- 79%
- Raised in a row
- 1 year
You receive $1.01 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Neutral- Buy 8
- Hold 14
- Sell 0
No analyst has published a price target.
36% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
The company reports no revenue by product.
By region
- UNITED STATES 40%
- Other countries 30%
- NETHERLANDS 14%
- CHINA 6.7%
- JAPAN 5.0%
- Other 3.7%
UNITED STATES brings in 40% of revenue.
Segments in detail